protein intake optimization glp-1 receptor agonists for Patients on Weight Loss Medications Nutritional priorities to support GLP-1
Description
More than 9000 patients were included with follow up of 3.8 years
Two studies in our review utilized data with at least 95% collected prior to the ASA's initial recommendation: (i) Alkabbani et al covered the period from January 2015 to August 2023
Leading companies such as Novo Nordisk, Eli Lilly, and Sanofi have contributed to market growth with innovative products, including once-weekly formulations to improve patient adherence
Emerging evidence indicates that GLP-1 and its analogues have direct protective effects on vascular endothelium 11
